Downregulation of HADH promotes gastric cancer progression via Akt signaling pathway

HADH is a key enzyme in fatty acid oxidation. The aim of this study was to identify the role of HADH in gastric cancer. We analyzed the expression of HADH in 102 pairs of gastric cancer samples. Western blot analysis revealed that HADH was decreased in stage I/II gastric cancer samples compared to matched adjacent normal gastric tissue, and its expression was further decreased in stage III/IV samples. Importantly, the reduced expression of HADH was associated with increased expression of p-Akt and reduced expression of PTEN in the gastric carcinoma tumor samples. To determine the significance of HADH downregulation in gastric cancer progression, we tested the impact of HADH knockdown or overexpression on the migration and invasion of the gastric cancer cells using a transwell assay. Knockdown of HADH significantly promoted gastric cancer cell migration and invasion, which was associated with increased expression of p-Akt. The PI3K inhibitor LY294002 inhibited HADH shRNA induced migration/invasion, and abolished the upregulation of p-Akt. By contrast, HADH overexpression inhibited the migration and invasion of MKN45 cells. Herein, for the first time, we demonstrate that downregulation of HADH promotes gastric cancer progression via activation of Akt signaling pathway.

[1]  Wei Wu,et al.  Vasodilator-stimulated phosphoprotein (VASP), a novel target of miR-4455, promotes gastric cancer cell proliferation, migration, and invasion, through activating the PI3K/AKT signaling pathway , 2018, Cancer Cell International.

[2]  Zheng Li,et al.  Netrin-1 promotes gastric cancer cell proliferation and invasion via the receptor neogenin through PI3K/AKT signaling pathway , 2017, OncoTarget.

[3]  F. Sotgia,et al.  Cancer metabolism: a therapeutic perspective , 2017, Nature Reviews Clinical Oncology.

[4]  T. Ma,et al.  HOXB7 overexpression promotes cell proliferation and correlates with poor prognosis in gastric cancer patients by inducing expression of both AKT and MARKs , 2016, Oncotarget.

[5]  Jin Wu,et al.  CXCL10/CXCR3 axis promotes the invasion of gastric cancer via PI3K/AKT pathway-dependent MMPs production. , 2016, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[6]  Junjie Xiao,et al.  Therapeutic inhibition of phospholipase D1 suppresses hepatocellular carcinoma. , 2016, Clinical science.

[7]  K. Yao,et al.  Intracellular mechanisms underlying lipid accumulation (white opaque substance) in gastric epithelial neoplasms: A pilot study of expression profiles of lipid‐metabolism‐associated genes , 2016, Journal of gastroenterology and hepatology.

[8]  W. Liao,et al.  Overexpression of fatty acid synthase predicts a poor prognosis for human gastric cancer , 2016, Molecular medicine reports.

[9]  T. Ma,et al.  Gamabufotalin, a major derivative of bufadienolide, inhibits VEGF-induced angiogenesis by suppressing VEGFR-2 signaling pathway , 2015, Oncotarget.

[10]  X. Qin,et al.  A concordant expression pattern of fatty acid synthase and membranous human epidermal growth factor receptor 2 exists in gastric cancer and is associated with a poor prognosis in gastric adenocarcinoma patients , 2015, Oncology letters.

[11]  Hong Chen,et al.  ATP citrate lyase expression is associated with advanced stage and prognosis in gastric adenocarcinoma. , 2015, International journal of clinical and experimental medicine.

[12]  J. Thiery,et al.  Adhesion glycoprotein CD44 functions as an upstream regulator of a network connecting ERK, AKT and Hippo-YAP pathways in cancer progression , 2014, Oncotarget.

[13]  Jianfang Li,et al.  CEACAM6 Promotes Gastric Cancer Invasion and Metastasis by Inducing Epithelial-Mesenchymal Transition via PI3K/AKT Signaling Pathway , 2014, PloS one.

[14]  Yi-chen Dai,et al.  Attenuation of enoyl coenzyme A hydratase short chain 1 expression in gastric cancer cells inhibits cell proliferation and migration in vitro , 2014, Cellular & Molecular Biology Letters.

[15]  M. Radman,et al.  Hepatocellular carcinoma protein carbonylation in virus C and metabolic syndrome patients. , 2014, Free radical biology & medicine.

[16]  G. Semenza,et al.  HIF-1-mediated suppression of acyl-CoA dehydrogenases and fatty acid oxidation is critical for cancer progression. , 2014, Cell reports.

[17]  Danyang Yu,et al.  Increased expression of phospho-acetyl-CoA carboxylase protein is an independent prognostic factor for human gastric cancer without lymph node metastasis , 2014, Medical Oncology.

[18]  Y. Kajiyama,et al.  Elevated levels of serum fatty acid synthase in patients with gastric carcinoma , 2014, Oncology letters.

[19]  T. Wang,et al.  Inhibition of fatty acid synthase suppresses U-2 OS cell invasion and migration via downregulating the activity of HER2/PI3K/AKT signaling pathway in vitro. , 2013, Biochemical and biophysical research communications.

[20]  X. Long,et al.  Inhibition of fatty acid synthase suppresses osteosarcoma cell invasion and migration via downregulation of the PI3K/Akt signaling pathway in vitro. , 2013, Molecular medicine reports.

[21]  K. Shirabe,et al.  Reduction of fatty acid oxidation and responses to hypoxia correlate with the progression of de-differentiation in HCC. , 2013, Molecular medicine reports.

[22]  W. Mustain,et al.  Inhibition of fatty acid synthase attenuates CD44-associated signaling and reduces metastasis in colorectal cancer. , 2012, Cancer research.

[23]  H. Kulkarni,et al.  Association of HADHA expression with the risk of breast cancer: targeted subset analysis and meta-analysis of microarray data , 2012, BMC Research Notes.

[24]  M. Sun,et al.  Enoyl coenzyme A hydratase 1 is an important factor in the lymphatic metastasis of tumors. , 2011, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[25]  A. Boner,et al.  3-hydroxyacyl-coenzyme a dehydrogenase deficiency: identification of a new mutation causing hyperinsulinemic hypoketotic hypoglycemia, altered organic acids and acylcarnitines concentrations. , 2012, JIMD reports.